Published in PLoS One on September 23, 2010
SnoN signaling in proliferating cells and postmitotic neurons. FEBS Lett (2012) 0.83
SnoN oncoprotein enhances estrogen receptor-α transcriptional activity. Cell Signal (2011) 0.80
The SWI/SNF Subunit INI1 Contains an N-Terminal Winged Helix DNA Binding Domain that Is a Target for Mutations in Schwannomatosis. Structure (2015) 0.77
SnoN Stabilizes the SMAD3/SMAD4 Protein Complex. Sci Rep (2017) 0.75
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res (2003) 38.75
Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol (1999) 33.07
ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics (1999) 21.85
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature (1997) 15.75
Version 1.2 of the Crystallography and NMR system. Nat Protoc (2007) 13.01
Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51
The CATH domain structure database: new protocols and classification levels give a more comprehensive resource for exploring evolution. Nucleic Acids Res (2006) 3.84
The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol (2001) 2.69
Protein-protein interaction and quaternary structure. Q Rev Biophys (2008) 2.64
Protein-protein docking benchmark version 3.0. Proteins (2008) 2.54
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52
Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev (1999) 2.15
Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res (2009) 2.07
Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res (1989) 1.91
The ski oncogene induces muscle differentiation in quail embryo cells. Cell (1989) 1.80
Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus. J Virol (1981) 1.68
Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol (1986) 1.64
Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell (2002) 1.54
Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein. Mol Cell Biol (2002) 1.50
Sequence and biological activity of chicken snoN cDNA clones. Oncogene (1993) 1.39
The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42. Oncogene (1998) 1.33
Structure of the retinal determination protein Dachshund reveals a DNA binding motif. Structure (2002) 1.22
Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins. Proc Natl Acad Sci U S A (2005) 1.14
Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. Proc Natl Acad Sci U S A (1998) 1.11
Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion. J Biol Chem (1999) 1.10
SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res (1993) 1.07
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia (2006) 1.06
Expression of the c-ski proto-oncogene in human melanoma cell lines. Melanoma Res (1993) 1.05
Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling. Mol Cell Neurosci (2007) 1.03
Crystal structure of the dachshund homology domain of human SKI. Structure (2004) 0.99
Identification of a core functional and structural domain of the v-Ski oncoprotein responsible for both transformation and myogenesis. Oncogene (1997) 0.99
A carboxyl-terminal region of the ski oncoprotein mediates homodimerization as well as heterodimerization with the related protein SnoN. J Biol Chem (1994) 0.97
Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents. Nucleic Acids Res (1999) 0.96
Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissues. Lab Invest (2005) 0.93
Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem (2006) 5.05
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc Natl Acad Sci U S A (2006) 4.45
Protein production and purification. Nat Methods (2008) 3.97
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet (2007) 3.95
In situ proteolysis for protein crystallization and structure determination. Nat Methods (2007) 3.05
Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science (2013) 2.74
Crystal structure of a divalent metal ion transporter CorA at 2.9 angstrom resolution. Science (2006) 2.23
Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization. Nat Struct Mol Biol (2011) 2.23
Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature (2007) 2.17
The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif (2007) 2.10
The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem (2008) 1.89
The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass. Science (2004) 1.53
An efficient strategy for high-throughput expression screening of recombinant integral membrane proteins. Protein Sci (2005) 1.48
Structural basis for recognition by an in vitro evolved affibody. Proc Natl Acad Sci U S A (2003) 1.46
The DEXD/H-box RNA helicase DDX19 is regulated by an {alpha}-helical switch. J Biol Chem (2009) 1.39
Displacement of the tyrosyl radical cofactor in ribonucleotide reductase obtained by single-crystal high-field EPR and 1.4-A x-ray data. Proc Natl Acad Sci U S A (2003) 1.38
Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor. J Med Chem (2010) 1.33
Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and HSPA5/BiP/GRP78. PLoS One (2010) 1.33
PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA. J Biol Chem (2010) 1.32
Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase. Nat Struct Mol Biol (2004) 1.32
Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3. J Med Chem (2009) 1.31
Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters. Nat Struct Mol Biol (2013) 1.31
His tag effect on solubility of human proteins produced in Escherichia coli: a comparison between four expression vectors. J Struct Funct Genomics (2004) 1.31
Structural basis of selective inhibition of human tankyrases. J Med Chem (2012) 1.25
Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates. Nat Methods (2009) 1.23
Crystal structure of a human mitochondrial deoxyribonucleotidase. Nat Struct Biol (2002) 1.22
Comparative structural analysis of human DEAD-box RNA helicases. PLoS One (2010) 1.21
Molecular and structural basis for redox regulation of beta-actin. J Mol Biol (2007) 1.20
Comparative structural analysis of lipid binding START domains. PLoS One (2011) 1.19
HalX: an open-source LIMS (Laboratory Information Management System) for small- to large-scale laboratories. Acta Crystallogr D Biol Crystallogr (2005) 1.19
Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888. Biochemistry (2010) 1.17
Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH). Hum Mutat (2008) 1.15
Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett (2008) 1.13
Zinc binding catalytic domain of human tankyrase 1. J Mol Biol (2008) 1.09
Structural and biophysical characterization of the cytoplasmic domains of human BAP29 and BAP31. PLoS One (2013) 1.09
Structure of Streptococcus agalactiae serine/threonine phosphatase. The subdomain conformation is coupled to the binding of a third metal ion. FEBS J (2007) 1.09
Crystal structure of the di-iron/radical protein of ribonucleotide reductase from Corynebacterium ammoniagenes. Biochemistry (2002) 1.08
Structural insights into substrate recognition in proton-dependent oligopeptide transporters. EMBO Rep (2013) 1.08
Adolescents' perception of bullying: who is the victim? Who is the bully? What can be done to stop bullying? Adolescence (2007) 1.08
Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli. Nat Methods (2005) 1.04
A trimetal site and substrate distortion in a family II inorganic pyrophosphatase. J Biol Chem (2006) 1.03
Engineering membrane protein overproduction in Escherichia coli. Protein Sci (2008) 1.03
Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus. FEBS J (2009) 1.02
Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition. J Biol Chem (2007) 1.02
The structure of the RNA m5C methyltransferase YebU from Escherichia coli reveals a C-terminal RNA-recruiting PUA domain. J Mol Biol (2006) 1.00
The structure of human collapsin response mediator protein 2, a regulator of axonal growth. J Neurochem (2007) 0.99
Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) beta-receptor but not the PDGF alpha-receptor. Mol Biol Cell (2006) 0.99
High-throughput crystal-optimization strategies in the South Paris Yeast Structural Genomics Project: one size fits all? Acta Crystallogr D Biol Crystallogr (2005) 0.97
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer. Cancer Res (2012) 0.96
Catalysis within the lipid bilayer-structure and mechanism of the MAPEG family of integral membrane proteins. Curr Opin Struct Biol (2008) 0.96
An efficient and generic strategy for producing soluble human proteins and domains in E. coli by screening construct libraries. Proteins (2006) 0.95
A high throughput method for the detection of metalloproteins on a microgram scale. Mol Cell Proteomics (2005) 0.94
Efficiency of hit generation and structural characterization in fragment-based ligand discovery. Curr Opin Chem Biol (2011) 0.94
Structural studies of metal ions in family II pyrophosphatases: the requirement for a Janus ion. Biochemistry (2004) 0.93
Structure of the synthetase domain of human CTP synthetase, a target for anticancer therapy. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.91
Crystal structure of the N-terminal NC4 domain of collagen IX, a zinc binding member of the laminin-neurexin-sex hormone binding globulin (LNS) domain family. J Biol Chem (2007) 0.91
High-throughput analytical gel filtration screening of integral membrane proteins for structural studies. Biochim Biophys Acta (2013) 0.91
Crystal structure of CaiB, a type-III CoA transferase in carnitine metabolism. Biochemistry (2004) 0.91
Arginine 104 is a key catalytic residue in leukotriene C4 synthase. J Biol Chem (2010) 0.91
Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site. J Biol Chem (2007) 0.91
The crystal structure of a human PP2A phosphatase activator reveals a novel fold and highly conserved cleft implicated in protein-protein interactions. J Biol Chem (2006) 0.90
EPR studies of the mitochondrial alternative oxidase. Evidence for a diiron carboxylate center. J Biol Chem (2002) 0.89
Biochemical discrimination between selenium and sulfur 1: a single residue provides selenium specificity to human selenocysteine lyase. PLoS One (2012) 0.89
Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II. J Mol Biol (2011) 0.89
Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors. Eur J Pharm Sci (2013) 0.89
X-ray structure of tRNA pseudouridine synthase TruD reveals an inserted domain with a novel fold. FEBS Lett (2004) 0.89
A prokaryotic alternative oxidase present in the bacterium Novosphingobium aromaticivorans. FEBS Lett (2003) 0.89
A simple strategy towards membrane protein purification and crystallization. Int J Biol Macromol (2006) 0.88
Structural and biophysical characterization of human myo-inositol oxygenase. J Biol Chem (2008) 0.88
Structural basis and selectivity of tankyrase inhibition by a Wnt signaling inhibitor WIKI4. PLoS One (2013) 0.88
Structural studies of tri-functional human GART. Nucleic Acids Res (2010) 0.88